Biomarker Testing, Surgical Outcomes, and Adjuvant Therapy Rates Among Patients with Resected Non-Small Cell Lung Cancer (NSCLC) in the Community Setting in the United States (US), 2019–2023
07:30am - 03:35pm EDT - April 6, 2024